Intelligent Ultrasound has sold its clinical AI business to GE HealthCare

Intelligent Ultrasound Group plc has completed the sale of its clinical AI software business to GE HealthCare for US$52.3 million. This cross-border transaction bolsters GE HealthCare’s ultrasound systems offering by enabling deeper integration of AI solutions to improve clinical workflows, reduce repetitive tasks and simplify examinations.

Intelligent Ultrasound Group plc (AIM: IUG) is one of the world’s leading classroom-to-clinic ultrasound companies, specializing in real-time, high-fidelity virtual reality simulation for the ultrasound training market and artificial intelligence-based clinical image analysis software tools for diagnostic medical ultrasound. Based in Cardiff, UK, and Atlanta, USA, the group has sold its clinical AI business comprising Intelligent Ultrasound Limited, the developer of medical ultrasound software, together with related clinical AI assets.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics and digital solutions provider, delivering integrated systems, services and data analytics to improve hospital efficiency, clinical effectiveness, therapeutic precision and patient outcomes. With more than 125 years of experience, the company advances patient care from diagnosis to therapy and monitoring, while simplifying the patient journey across the care pathway. GE HealthCare operates across imaging, ultrasound and image-guided therapies, patient care solutions and pharmaceutical diagnostics, and is a US$19.6 billion business employing approximately 51,000 people.

Oaklins Cavendish, one of Oaklins’ member firms in the UK, advised Intelligent Ultrasound Group plc on the sale of its clinical AI business to GE HealthCare.